Seriously, this was a badly conceived blog apart from the manifold English mistakes. The thesis that Teva’s Lovenox ANDA is a hedge against loss of Copaxone exclusivity is just plain silly, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.